Co-targeting the gut–brain axis using noninvasive transcutaneous VNS alongside personalised microbiome interventions alongside personalised microbiome interventions offers a promising direction for precision medicine.
Said Salim Said, C. Okafor, Burhani Simai· Apollo Medicine· 0 citations
Continuous technological innovation, prospective multicenter validation, standardized testing protocols, and evidence-based clinical guidelines are essential to fully integrate ctDNA into routine precision breast cancer care.
E. I. Obeagu, C. Okafor· Breast Cancer: Basic and Cli...· 0 citations
POCT glucose measurements show excellent correlation with laboratory auto-analyser results but exhibit systematic and proportional bias, particularly at higher glucose levels, particularly at higher glucose levels.
Ufuoma Ohwo, K. Digban, C. Okafor· Apollo Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.